These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20883512)

  • 21. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short QT syndrome. Update on a recent entity.
    Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
    Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
    Miles RH; Passman R; Murdock DK
    Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation.
    Shah SA; Koyama G; Da Costa D; McGregor P; Kolasa M
    Int J Cardiol; 2014 Apr; 172(3):e428-9. PubMed ID: 24461967
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker.
    van den Berg MP; van den Heuvel F; van Tintelen JP; Volders PG; van Gelder IC
    Int J Cardiol; 2014 Jan; 171(1):90-2. PubMed ID: 24342415
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report].
    Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phenotypic combination of idiopathic VF and Brugada syndrome.
    Martinek M; Purerfellner H
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 30. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of tachycardiac disorders of the heart rhythm by beta-receptor block of the atrioventricular tissue].
    Bender F; Kojima N; Reploh HD; Oelmann G
    Med Welt; 1966 May; 20():1120-3. PubMed ID: 5984492
    [No Abstract]   [Full Text] [Related]  

  • 32. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
    Michel B; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome.
    Chinushi M; Iijima K; Tagawa M; Komura S; Furushima H; Aizawa Y
    J Electrocardiol; 2009; 42(4):367-73. PubMed ID: 19356768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-arrhythmic therapy with verapamil by intravenous infusion].
    Furlanello F; Piccolo E; Disertori M; Trevi GP; Lanzetta T; Miori
    Minerva Med; 1975 May; 66(39):1887-903. PubMed ID: 1128829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 36. Ranolazine: new drug. Stable angina: not worth the risk.
    Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A successfully novel ICD implantation and medical treatment in a child with LQT syndrome and self-limiting ventricular fibrillation.
    Drago F; Fazio G; Silvetti MS; Oricchio G; Michelon G
    Int J Cardiol; 2007 Jun; 118(3):e108-12. PubMed ID: 17408769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinus node dysfunction in ATX-II-induced in-vitro murine model of long QT3 syndrome and rescue effect of ranolazine.
    Wu J; Cheng L; Lammers WJ; Wu L; Wang X; Shryock JC; Belardinelli L; Lei M
    Prog Biophys Mol Biol; 2008; 98(2-3):198-207. PubMed ID: 19351514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?
    Schotten U; Verheule S; Kerfant BG; Greiser M
    J Am Coll Cardiol; 2010 May; 55(21):2343-5. PubMed ID: 20488305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.